INTELLIGENT BIO SOLUTIONS INC(INBS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

INBS INTELLIGENT BIO SOLUTIONS INC

Post-Market Trading 11-25 16:56:34 EST

1.51

-0.04

-2.58%

盘后1.55

+0.04+2.65%

16:14 EST

High1.56	Low1.45	Vol145.97K
Open1.53	D1 Closing1.55	Amplitude7.10%
Mkt Cap6.62M	Tradable Cap6.46M	Total Shares4.39M
T/O221.00K	T/O Rate3.41%	Tradable Shares4.28M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"INBS","market":"US","secType":"STK","nameCN":"INTELLIGENT BIO SOLUTIONS INC","latestPrice":1.51,"timestamp":1732568400000,"preClose":1.55,"halted":0,"volume":145970,"hourTrading":{"tag":"盘后","latestPrice":1.55,"preClose":1.51,"latestTime":"16:14 EST","volume":102,"amount":154.1800074,"timestamp":1732569274803},"delay":0,"floatShares":4276172,"shares":4386700,"eps":-4.171933,"marketStatus":"Post-Market Trading","change":-0.04,"latestTime":"11-25 16:56:34 EST","open":1.53,"high":1.56,"low":1.45,"amount":221004.417144,"amplitude":0.070968,"askPrice":1.55,"askSize":200,"bidPrice":1.5,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-4.171933,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1732582800000},"marketStatusCode":4,"adr":0,"listingDate":1608699600000,"exchange":"NASDAQ","adjPreClose":1.55,"preHourTrading":{"tag":"盘前","latestPrice":1.58,"preClose":1.55,"latestTime":"09:28 EST","volume":12947,"amount":20231.456060200002,"timestamp":1732544880330},"postHourTrading":{"tag":"盘后","latestPrice":1.55,"preClose":1.51,"latestTime":"16:14 EST","volume":102,"amount":154.1800074,"timestamp":1732569274803},"volumeRatio":0.818884},"requestUrl":"/m/hq/s/INBS/wiki","defaultTab":"wiki","newsList":[{"id":"2485302499","title":"Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2485302499","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485302499?lang=en_us&edition=fundamental","pubTime":"2024-11-21 21:30","pubTimestamp":1732195800,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov.  21, 2024  (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/21/2985215/0/en/Intelligent-Bio-Solutions-to-Participate-in-the-Noble-Capital-Markets-20th-Annual-Emerging-Growth-Equity-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBL","INBS","BK4588","EQR","BK4215","BK4585","BK4082"],"gpt_icon":1},{"id":"2484095076","title":"INBS Stock Declines Despite Positive Results of Pharmacokinetic Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2484095076","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484095076?lang=en_us&edition=fundamental","pubTime":"2024-11-18 23:55","pubTimestamp":1731945300,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions Inc. INBS recently announced positive initial results from its Pharmacokinetic  study. The study is important for supporting FDA 510 clearance of the company’s Intelligent Fingerprinting Drug Screening technology.Per the PK study's data, the amount and rate of codeine in blood and saliva are mimicked by fingerprint sweat. Based on 95% confidence level statistical comparisons, the study effectively demonstrated that fingerprint sweat offers a dependable sample matrix for drug detection, displaying quantitative PK data well aligned with blood.Following the news annoucement, shares of the company have moved nearly 12.4% south to $1.48 on Friday’s closing . In the year-to-date period, INBS shares have plunged 63.5% compared with the industry’s 10.2% decline. The S&P 500 increased 23.4% in the same time frame.Meanwhile, INBS currently has a market capitalization of $6.5 million.More on the INBS Intelligent Fingerprinting Drug Screening System","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/QieiOVP5CdM1cfxTnlcVfQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/QieiOVP5CdM1cfxTnlcVfQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e797ee31d4bee954c41ecfac218dc795"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inbs-stock-declines-despite-positive-155500850.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PK","LU0205193047.USD","GMED","BK4082","MASI","LU0240878834.USD","INBS","BK4218","BK4181","LU0205194284.USD","IE0009354923.USD","LU0240877869.USD","LU2065732104.USD","ANGO"],"gpt_icon":0},{"id":"2483286696","title":"Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024)","url":"https://stock-news.laohu8.com/highlight/detail?id=2483286696","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483286696?lang=en_us&edition=fundamental","pubTime":"2024-11-14 02:39","pubTimestamp":1731523148,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions ( NASDAQ:INBS ) First Quarter 2025 Results Key Financial Results Revenue: US$872.3k (up 9.6...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-inbs/intelligent-bio-solutions/news/intelligent-bio-solutions-first-quarter-2025-earnings-us070","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["INBS"],"gpt_icon":0},{"id":"2483828888","title":"BRIEF-Intelligent Bio Solutions Announces Positive Results Of PK Study, A Key Milestone On Path To FDA 510(K) Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2483828888","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483828888?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:35","pubTimestamp":1731504902,"startTime":"0","endTime":"0","summary":"Nov 13  - Intelligent Bio Solutions Inc :   * INTELLIGENT BIO SOLUTIONS ANNOUNCES POSITIVE RESULTS OF PK STUDY, A KEY MILESTONE ON PATH TO FDA 510 SUBMISSION   * INTELLIGENT BIO SOLUTIONS INC - FDA 510 CLEARANCE COULD INTRODUCE INBS TECHNOLOGY TO US IN 2025Source text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","INBS","K","PK","BK4181","BK4588","BK4218","BK4212","BK4082","BK4504"],"gpt_icon":0},{"id":"2483000216","title":"Intelligent Bio Solutions Inc - FDA 510(K) Clearance Could Introduce Inbs Technology to US in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2483000216","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483000216?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:30","pubTimestamp":1731504602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUA3NK371:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","INBS"],"gpt_icon":0},{"id":"2483000023","title":"Intelligent Bio Solutions Announces Positive Results of Pk Study, a Key Milestone on Path to FDA 510(K) Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2483000023","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483000023?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:30","pubTimestamp":1731504602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUA3NK371:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBS","BK4082"],"gpt_icon":0},{"id":"2483851888","title":"Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission","url":"https://stock-news.laohu8.com/highlight/detail?id=2483851888","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483851888?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:30","pubTimestamp":1731504600,"startTime":"0","endTime":"0","summary":"PK Study Successfully Demonstrates that Fingerprint Sweat Provides Reliable Sample for Drug Detection FDA 510(k) Clearance Would Enable the Introduction of INBS’ Technology to the US in 2025 NEW YORK,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/13/2980281/0/en/Intelligent-Bio-Solutions-Announces-Positive-Results-of-PK-Study-a-Key-Milestone-on-Path-to-FDA-510-k-Submission.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4181","BK4218","INBS","BK4082","PK"],"gpt_icon":1},{"id":"2482226659","title":"Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482226659","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482226659?lang=en_us&edition=fundamental","pubTime":"2024-11-10 21:33","pubTimestamp":1731245604,"startTime":"0","endTime":"0","summary":"NasdaqCM:INBS Earnings and Revenue History November 10th 2024. All figures shown in the chart above are for the trailing 12 month  period. Intelligent Bio Solutions shares are up 17% from a week ago.Before you take the next step you should know about the 6 warning signs for Intelligent Bio Solutions (5 are significant!","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/intelligent-bio-solutions-first-quarter-133324072.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INBS"],"gpt_icon":0},{"id":"2481900160","title":"Intelligent Bio Solutions Q1 EPS $(0.70) Misses $(0.53) Estimate, Sales $872.29K Miss $1.75M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481900160","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481900160?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:53","pubTimestamp":1730987632,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions (NASDAQ:INBS) reported quarterly losses of $(0.70) per share which missed the analyst consensus estimate of $(0.53) by 32.08 percent. This is a 94.39 percent increase over losses of $(12.48) per","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41807459/intelligent-bio-solutions-q1-eps-0-70-misses-0-53-estimate-sales-872-29k-miss-1-75m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Intelligent Bio Solutions Q1 EPS $(0.70) Misses $(0.53) Estimate, Sales $872.29K Miss $1.75M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBS"],"gpt_icon":1},{"id":"2481078169","title":"Intelligent Bio Solutions Q1 Basic EPS USD -0.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2481078169","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481078169?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:30","pubTimestamp":1730986201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nPLX732DD0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBS","BK4082"],"gpt_icon":0},{"id":"2481079759","title":"Press Release: Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2481079759","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481079759?lang=en_us&edition=fundamental","pubTime":"2024-11-07 21:30","pubTimestamp":1730986200,"startTime":"0","endTime":"0","summary":"Quarterly revenue increased 10% year-on-year and 20% quarter-on-quarter, marking four consecutive quarters of year-on-year growth. Higher-margin, recurring cartridge revenue surpassed reader revenue as primary driver. Completed in-clinic portion of FDA 510 clinical study plan, on track to submit to FDA by year-end. Initial review of PK study results show fingerprint sweat strongly aligns to blood and oral fluid, results expected in November. \"Our focus on higher-margin cartridge sales and strategic global expansion is creating a solid foundation for revenue growth and financial stability,\" added Spiro Sakiris, CFO of Intelligent Bio Solutions. \"Our expanding distributor network enables us to meet rising global demand. With a 15% increase in international sales, we are on track to achieve our strategic goal of broadening our global reach and supporting workplace safety worldwide.\". -- On September 27, 2024, the Company announced the successful completion of","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBS","BK4082"],"gpt_icon":0},{"id":"2479081656","title":"Intelligent Bio partners with B2i Digital to amplify investor outreach","url":"https://stock-news.laohu8.com/highlight/detail?id=2479081656","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479081656?lang=en_us&edition=fundamental","pubTime":"2024-10-31 20:47","pubTimestamp":1730378861,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions (INBS) announced a strategic partnership with B2i Digital to launch an investor-focused marketing campaign. B2i Digital w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/intelligent-bio-partners-with-b2i-digital-to-amplify-investor-outreach?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/intelligent-bio-partners-with-b2i-digital-to-amplify-investor-outreach?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INBS","BK4082"],"gpt_icon":0},{"id":"2479089401","title":"Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach","url":"https://stock-news.laohu8.com/highlight/detail?id=2479089401","media":"GlobeNewswire","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479089401?lang=en_us&edition=fundamental","pubTime":"2024-10-31 20:30","pubTimestamp":1730377800,"startTime":"0","endTime":"0","summary":"Digital Marketing Initiatives to Highlight Innovative Non-Invasive Drug Screening Technology and Market Expansion Plans. “Intelligent Bio Solutions has developed a groundbreaking system that addresses a critical need in industries requiring quick and reliable drug screening,” said David Shapiro, CEO of B2i Digital. “The company’s Intelligent Fingerprinting Drug Screening System, expected to enter the U.S. market next year following the company’s FDA 510 submission and anticipated clearance, provides substantial advantages over traditional methods and offers significant growth potential. We are proud to raise awareness of a company whose products address a critical need across industries worldwide.”B2i Digital, Inc. leverages the latest digital marketing technologies to tell a company’s story to retail investors, institutional investors, and research analysts. B2i Digital creates robust profiles for companies on its platform, b2idigital.com, and launches targeted digital marketing campa","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/uWsK6oir1plkkTWI2ddevw--~B/aD04NDA7dz00NzE0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/112709418e5be294adb1ae4f93f476f3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/uWsK6oir1plkkTWI2ddevw--~B/aD04NDA7dz00NzE0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/112709418e5be294adb1ae4f93f476f3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/intelligent-bio-solutions-partners-b2i-123000630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INBS","BK4082"],"gpt_icon":1},{"id":"2479940133","title":"Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2479940133","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479940133?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:30","pubTimestamp":1730205000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nTUA4XKPTY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","INBS"],"gpt_icon":0},{"id":"2479401785","title":"Press Release: Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2479401785","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479401785?lang=en_us&edition=fundamental","pubTime":"2024-10-29 20:30","pubTimestamp":1730205000,"startTime":"0","endTime":"0","summary":"Unaudited quarterly revenue increased 10% year-on-year and 20% quarter-on-quarter. Higher-margin, recurring cartridge revenue expected to surpass reader revenue as primary driver. NEW YORK, Oct. 29, 2024  -- Intelligent Bio Solutions Inc.  , a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced preliminary unaudited revenue results for the fiscal first quarter ended September 30, 2024.\"While we are pleased with another quarter of year-on-year and sequential revenue growth, it is important to note that now, with our readers in the market and over 400 active customer accounts, we are beginning to yield the benefits of higher-margin, recurring revenue from the sale of cartridges. This shift shows a growing confidence in the dependability and quality of our products amongst our strong and growing customer base,\" said Harry Simeonidis, President and CEO at Intelligent Bio Solutions. \"Customer loyalty and advocacy of our products is drivi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBS"],"gpt_icon":0},{"id":"2477278638","title":"Intelligent Bio Solutions Celebrates One Year Anniversary of Enhanced Workplace Safety with London-Based Real-Estate Developer, Mount Anvil","url":"https://stock-news.laohu8.com/highlight/detail?id=2477278638","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477278638?lang=en_us&edition=fundamental","pubTime":"2024-10-24 20:30","pubTimestamp":1729773000,"startTime":"0","endTime":"0","summary":"Developer Praises Intelligent Bio Solutions’ Innovative Drug Testing Solution for Improving Workplace Safety. NEW YORK, Oct. 24, 2024  -- Intelligent Bio Solutions Inc.  , a medical technology company offering non-invasive, rapid testing solutions, today announced that its customer Mount Anvil, one of London's most respected property developers, has celebrated its one-year anniversary of enhanced workplace safety after integrating INBS’ Intelligent Fingerprinting Drug Screening Solution into its operations.The successful integration of INBS’ technology reflects a mutual dedication to innovation and workplace safety between Mount Anvil and INBS.Intelligent Bio Solutions Inc.  is a medical technology company delivering innovative, rapid, non-invasive testing solutions to more than 400 customers in 19 countries. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/uWsK6oir1plkkTWI2ddevw--~B/aD04NDA7dz00NzE0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/112709418e5be294adb1ae4f93f476f3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/uWsK6oir1plkkTWI2ddevw--~B/aD04NDA7dz00NzE0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/112709418e5be294adb1ae4f93f476f3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/intelligent-bio-solutions-celebrates-one-123000253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","INBS","WRD"],"gpt_icon":0},{"id":"2476776945","title":"Intelligent Bio Solutions to Present at the LD Micro Main Event XVII on October 28-30 in Los Angeles","url":"https://stock-news.laohu8.com/highlight/detail?id=2476776945","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476776945?lang=en_us&edition=fundamental","pubTime":"2024-10-16 20:00","pubTimestamp":1729080000,"startTime":"0","endTime":"0","summary":"New York, New York-- - Intelligent Bio Solutions Inc.  , a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will present in the upcoming LD Micro Main Event XVII on October 28-30, 2024, in Los Angeles.Management will be available during the event for 1x1 meetings with the investment community. To schedule a meeting, please contact your LD Micro representative or KCSA Strategic Communications by emailing INBS@kcsa.com.Intelligent Bio Solutions Inc.  is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/intelligent-bio-solutions-present-ld-120000131.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/intelligent-bio-solutions-present-ld-120000131.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","LD","INBS"],"gpt_icon":0},{"id":"2475926363","title":"Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek","url":"https://stock-news.laohu8.com/highlight/detail?id=2475926363","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475926363?lang=en_us&edition=fundamental","pubTime":"2024-10-14 20:00","pubTimestamp":1728907200,"startTime":"0","endTime":"0","summary":"Transition will Minimize Downtime, Deliver Faster, More Cost-Effective Results, and Improve Overall Safety and ProductivityNEW YORK, Oct.  14, 2024  (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/14/2962477/0/en/Intelligent-Bio-Solutions-Announces-Adoption-of-its-Non-Invasive-Drug-Screening-Solution-by-Global-Engineering-Leader-Pyrotek.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBS","BK4082"],"gpt_icon":0},{"id":"2474242455","title":"Intelligent Bio Solutions Partners with Spirit Group as Australian Distributor, Expanding Community Impact with Intelligent Fingerprinting Drug Testing Solution","url":"https://stock-news.laohu8.com/highlight/detail?id=2474242455","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474242455?lang=en_us&edition=fundamental","pubTime":"2024-10-09 20:30","pubTimestamp":1728477000,"startTime":"0","endTime":"0","summary":"NEW YORK, Oct.  09, 2024  (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/09/2960504/0/en/Intelligent-Bio-Solutions-Partners-with-Spirit-Group-as-Australian-Distributor-Expanding-Community-Impact-with-Intelligent-Fingerprinting-Drug-Testing-Solution.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBS","BK4082"],"gpt_icon":1},{"id":"2472322770","title":"GPS Marine Adopts Intelligent Bio Solutions’ Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2472322770","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472322770?lang=en_us&edition=fundamental","pubTime":"2024-10-01 20:30","pubTimestamp":1727785800,"startTime":"0","endTime":"0","summary":"NEW YORK, Oct. 01, 2024  -- Intelligent Bio Solutions Inc.  , a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the addition of GPS Marine, a leading provider of marine construction and logistics services, to its growing number of customer accounts.Intelligent Bio Solutions Inc.  is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for e","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/uWsK6oir1plkkTWI2ddevw--~B/aD04NDA7dz00NzE0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/112709418e5be294adb1ae4f93f476f3","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/uWsK6oir1plkkTWI2ddevw--~B/aD04NDA7dz00NzE0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/112709418e5be294adb1ae4f93f476f3"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gps-marine-adopts-intelligent-bio-123000602.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INBS","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ibs.inc","stockEarnings":[{"period":"1week","weight":0.0473},{"period":"1month","weight":0.0616},{"period":"3month","weight":0.3136},{"period":"6month","weight":-0.329},{"period":"1year","weight":-0.5515},{"period":"ytd","weight":-0.6177}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0303},{"period":"3month","weight":0.0594},{"period":"6month","weight":0.1248},{"period":"1year","weight":0.3088},{"period":"ytd","weight":0.2529}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.63337},{"month":2,"riseRate":0.25,"avgChangeRate":-0.088538},{"month":3,"riseRate":0.25,"avgChangeRate":-0.00878},{"month":4,"riseRate":0,"avgChangeRate":-0.263123},{"month":5,"riseRate":0.25,"avgChangeRate":-0.07011},{"month":6,"riseRate":0.75,"avgChangeRate":0.071421},{"month":7,"riseRate":0.25,"avgChangeRate":-0.178421},{"month":8,"riseRate":0.25,"avgChangeRate":-0.033737},{"month":9,"riseRate":0.25,"avgChangeRate":-0.187157},{"month":10,"riseRate":0.25,"avgChangeRate":-0.286504},{"month":11,"riseRate":0.5,"avgChangeRate":0.214862},{"month":12,"riseRate":0,"avgChangeRate":-0.302808}],"exchange":"NASDAQ","name":"INTELLIGENT BIO SOLUTIONS INC","nameEN":"INTELLIGENT BIO SOLUTIONS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INTELLIGENT BIO SOLUTIONS INC(INBS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INTELLIGENT BIO SOLUTIONS INC(INBS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INTELLIGENT BIO SOLUTIONS INC,INBS,INTELLIGENT BIO SOLUTIONS INC股票,INTELLIGENT BIO SOLUTIONS INC股票老虎,INTELLIGENT BIO SOLUTIONS INC股票老虎国际,INTELLIGENT BIO SOLUTIONS INC行情,INTELLIGENT BIO SOLUTIONS INC股票行情,INTELLIGENT BIO SOLUTIONS INC股价,INTELLIGENT BIO SOLUTIONS INC股市,INTELLIGENT BIO SOLUTIONS INC股票价格,INTELLIGENT BIO SOLUTIONS INC股票交易,INTELLIGENT BIO SOLUTIONS INC股票购买,INTELLIGENT BIO SOLUTIONS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INTELLIGENT BIO SOLUTIONS INC(INBS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INTELLIGENT BIO SOLUTIONS INC(INBS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}